These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2643291)

  • 1. Metabolic consequences of the alpha-glucosidase inhibitor BAY-M-1099 given to nondiabetic and diabetic rats fed a high-carbohydrate diet.
    Madar Z
    Am J Clin Nutr; 1989 Jan; 49(1):106-11. PubMed ID: 2643291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the alpha-glucosidase inhibitor Bay-O-1248 on the metabolic response of nondiabetic and diabetic rats to a high-carbohydrate diet.
    Madar Z; Olefsky J
    Am J Clin Nutr; 1986 Aug; 44(2):206-11. PubMed ID: 3728357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a glucosidase inhibitor on the metabolic response of diabetic rats to a high carbohydrate diet, consisting of starch and sucrose, or glucose.
    Gray RS; Olefsky JM
    Metabolism; 1982 Jan; 31(1):88-92. PubMed ID: 7043164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycemic and hormonal responses after repetitive sucrose and starch loads by different doses of the alpha-glucosidase inhibitor miglitol (BAY m 1099) in man.
    Lembcke B; Fölsch UR; Gatzemeier W; Ebert R; Siegel E; Creutzfeldt W
    Pharmacology; 1991; 43(6):318-28. PubMed ID: 1784628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats.
    Madar Z
    J Nutr; 1989 Dec; 119(12):2023-9. PubMed ID: 2695605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitus.
    Kennedy FP; Gerich JE
    Clin Pharmacol Ther; 1987 Oct; 42(4):455-8. PubMed ID: 3311550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes.
    Heinz G; Komjati M; Korn A; Waldhäusl W
    Eur J Clin Pharmacol; 1989; 37(1):33-6. PubMed ID: 2687007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients?
    Johnson AB; Taylor R
    Diabetes Care; 1996 Jun; 19(6):559-63. PubMed ID: 8725851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Delayed absorption of carbohydrates in the therapy of Type II diabetes: comparison between dietary (Muesli) and pharmacological (Alpha-glucosidase inhibition) modification].
    Willms B; Lübke D; Ahrens K; Arends J
    Schweiz Med Wochenschr; 1991 Sep; 121(38):1379-82. PubMed ID: 1656521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of two new alpha-glucosidase inhibitors on metabolic responses to a mixed meal in normal volunteers.
    Kennedy FP; Miles JM; Heiling V; Gerich JE
    Clin Exp Pharmacol Physiol; 1987 Aug; 14(8):633-40. PubMed ID: 3326689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses.
    Requejo F; Uttenthal LO; Bloom SR
    Diabet Med; 1990 Jul; 7(6):515-20. PubMed ID: 2163805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal and metabolic responses to an alpha-glucosidase inhibitor in normal volunteers.
    Holt PR; Thea D; Yang MY; Kotler DP
    Metabolism; 1988 Dec; 37(12):1163-70. PubMed ID: 3057329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the intestinal glucosidase inhibitory BAY M 1099 (miglitol) on glycemic status of obese-diabetic rats.
    DeBouno JF; Michaelis OE; Tulp OL
    Gen Pharmacol; 1993 Mar; 24(2):509-15. PubMed ID: 8482529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients.
    Schnack C; Röggla G; Luger A; Schernthaner G
    Eur J Clin Pharmacol; 1986; 30(4):417-9. PubMed ID: 3527720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miglitol (BAY m 1099) treatment of diabetic hypothalamic-dietary obese rats improves islet response to glucose.
    Axen KV; Li X; Sclafani A
    Obes Res; 1999 Jan; 7(1):83-9. PubMed ID: 10023734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of new alpha-glucosidase inhibitors (BAY m 1099 and BAY o 1248) on meal-stimulated increases in glucose and insulin levels in man.
    Hillebrand I; Boehme K; Graefe KH; Wehling K
    Klin Wochenschr; 1986 Apr; 64(8):393-6. PubMed ID: 3517475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial glycemic control, hormonal effects and carbohydrate malabsorption during long-term administration of the alpha-glucosidase inhibitor miglitol.
    Lembcke B; Diederich M; Fölsch UR; Creutzfeldt W
    Digestion; 1990; 47(1):47-55. PubMed ID: 2292349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of miglitol and acarbose on starch digestion, daily plasma glucose profiles and cataract formation.
    Madar Z; Hazan A
    J Basic Clin Physiol Pharmacol; 1993; 4(1-2):69-81. PubMed ID: 8679512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the alpha-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers.
    Lembcke B; Fölsch UR; Gatzemeier W; Lücke B; Ebert R; Siegel E; Creutzfeldt W
    Eur J Clin Pharmacol; 1991; 41(6):561-7. PubMed ID: 1815967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of an absorbable alpha-glucosidase inhibitor (Bay o 1248) on the endocrine and exocrine pancreas of the rat.
    Göke B; Fehmann HC; Siegel EG; Fölsch UR; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):758-66. PubMed ID: 2435069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.